Zurcher Kantonalbank (Zurich Cantonalbank) Applied Therapeutics Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 25,778 shares of APLT stock, worth $16,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,778Holding current value
$16,240% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$7.25 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$6.29 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$6.06 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$5.55 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$5.52 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $30.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...